Sacco System is an Italian owned multinational company that is a biotech hub for the food, nutraceutical, and pharmaceutical industries. A family-owned company active since 1872, Sacco System has grown organically and through strategic M&As to reach its current form. Sacco System continue to focus on bacterial manufacturing, research and development for nutraceutical and pharmaceutical fields. Our expertise helps solving consumer needs in more than 110 countries around the world, leveraging on our unique proprietary strains and customised blends. Our know-how is not limited to the lab, but with our two cGMP certified facilities we can support companies through development, process validation, and commercial production of probiotics, postbiotics, Next-Generation bacteria (obligate aerobic and anaerobic strains) and live biotherapeutics (LBPs). We continue to invest in Italy and abroad to ensure that we can offer cutting edge technologies to ensure our customers’ success.